IL6 and breast carcinoma: In previous studies in breast cancer CTCs, over expression of IL-6 and IL-1β or both in CTC-associated neutrophils was sufficient to confer proliferative advantage to breast cancer cells upon dissemination, leading to faster metastasis development and shorter overall survival in mice [48].